NCT06801418View on ClinicalTrials.gov

Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

June 19, 2025

Study Completion Date

June 19, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

Adagrasib

Specified dose on specified days

Trial Locations (3)

66219-9746

Local Institution - 0003, Lenexa

78209-1028

Local Institution - 0002, San Antonio

84124-1365

Local Institution - 0001, Salt Lake City

Sponsors
All Listed Sponsors
lead

Mirati Therapeutics Inc.

INDUSTRY

NCT06801418 - Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets | Biotech Hunter | Biotech Hunter